跳至主要内容
临床试验/NL-OMON53657
NL-OMON53657招募中不适用

Advanced MRI techniques and biomarkers to substitute gadolinium enhanced MRI for the detection of disease activity in multiple sclerosis. - ACTIVITY

Amsterdam UMC0 个研究点目标入组 75 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
75

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 99(—)

入选标准

  • To be eligible for this study, the participant must meet the following
  • Diagnosed as CIS, RRMS, PPMS based on McDonald criteria (2017)
  • Adult (18-70 years old)
  • Signed informed consent
  • Separate inclusion criteria will be applied for the active and inactive
  • For the active subgroup:
  • one or more Gd-enhancing lesion on brain MRI or signs of clinical disease
  • For the inactive subgroup:
  • no Gd enhancing lesion on brain MRI and no clinical signs of disease activity.

排除标准

  • A potential participant will be excluded from the study based on the following
  • contra-indications for MRI
  • History of (psychiatric) disorder which causes the patient to be incompetent to
  • make a well-informed decision
  • Other concurrent neurological disease

研究者

发起方
Amsterdam UMC

相似试验